Noramco and SPI Pharma sign agreement to develop ready-to-implement, patient-friendly formulations for pharmaceutical manufacturers
Noramco, a global leader in the manufacture and supply of controlled substance active pharmaceutical ingredients (APIs), and SPI Pharma, a global leader in the manuf...

















